The therapeutic community is buzzing with anticipation surrounding retatrutide, a innovative dual GIP and GLP-1 agonist that’s demonstrating significant promise in clinical trials for treating obesity. Unlike some existing weight loss solutions, retatrutide appears to retatrutide good or bad provide a more substantial decrease in body size and be